Feline hypertrophic cardiomyopathy: reduced microvascular density and involvement of CD34+ interstitial cells

Josep M Monné Rodríguez1,2,3, Sonja Fonfara1,4, Udo Hetzel1,2

  • 1The Veterinary Cardiac Pathophysiology Consortium.

Veterinary Pathology
|December 27, 2021
PubMed

Insights

Microvascular changes and interstitial cell alterations are key in feline hypertrophic cardiomyopathy (fHCM) development. Resident macrophages and CD34+ progenitor cells contribute to the disease

Area of Science:

  • Cardiology
  • Veterinary Pathology
  • Cell Biology

Background:

  • Feline hypertrophic cardiomyopathy (fHCM) pathogenesis remains unclear.
  • fHCM involves interstitial remodeling, inflammation, and potential myocardial ischemia.
  • Understanding structural changes in fHCM is crucial for diagnosis and treatment.

Purpose of the Study:

  • Investigate structural changes in interstitial remodeling in fHCM.
  • Focus on myocardial microvasculature and interstitial cell phenotypes.
  • Elucidate the role of specific cell populations in fHCM.

Main Methods:

  • Immunohistochemistry
  • RNA-in situ hybridization
  • Transmission electron microscopy
  • Morphometrical evaluations

Main Results:

  • Reduced microvascular density in fHCM hearts.
  • Capillary structural alterations and interstitial widening.
  • Accumulation of edema, collagen, and mononuclear cells.
  • Interstitial cells include fibroblasts, vascular cells, and resident macrophages.
  • CD34 mRNA expression suggests progenitor cell potential.

Conclusions:

  • Microvascular alterations are central to fHCM pathogenesis.
  • Interstitial cell populations, particularly CD34+ cells, are implicated in fHCM.
  • Macrophages play a significant role in the pro-inflammatory environment of fHCM.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
86
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
60
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
115
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
60
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
87
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
96